Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study
| dc.rights.license | open | en_US |
| dc.contributor.author | MULLER, Allison | |
| dc.contributor.author | BERTRAND, Xavier | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | ROGUES, Anne-Marie | |
| dc.contributor.author | PEFAU, Muriel | |
| dc.contributor.author | ALFANDARI, Serge | |
| dc.contributor.author | GAUZIT, Remy | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | DUMARTIN, Catherine | |
| dc.contributor.author | GBAGUIDI-HAORE, Houssein | |
| dc.date.accessioned | 2021-04-22T12:15:33Z | |
| dc.date.available | 2021-04-22T12:15:33Z | |
| dc.date.issued | 2018-12 | |
| dc.identifier.issn | 2047-2994 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/27033 | |
| dc.description.abstractEn | The ongoing extended spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) pandemic has led to an increasing carbapenem use, requiring release of guidelines for carbapenem usage in France in late 2010. We sought to determine factors associated with changes in carbapenem use in intensive care units (ICUs), medical and surgical wards between 2009 and 2013. | |
| dc.language.iso | EN | en_US |
| dc.rights | Attribution 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
| dc.subject.en | Antibiotic stewardship | |
| dc.subject.en | Antibiotic use | |
| dc.subject.en | Carbapenem | |
| dc.subject.en | ESBL | |
| dc.subject.en | Multidrug-resistant bacteria | |
| dc.title.en | Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study | |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1186/s13756-018-0302-8 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Microbiologie et Parasitologie | en_US |
| dc.identifier.pubmed | 29387345 | en_US |
| bordeaux.journal | Antimicrobial Resistance and Infection Control | en_US |
| bordeaux.page | 11 | en_US |
| bordeaux.volume | 7 | en_US |
| bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
| bordeaux.issue | 1 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | INSERM | en_US |
| bordeaux.team | PharmacoEpi-Drugs | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.import.source | hal | |
| hal.identifier | hal-01812646 | |
| hal.version | 1 | |
| hal.export | false | |
| workflow.import.source | hal | |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Antimicrobial%20Resistance%20and%20Infection%20Control&rft.date=2018-12&rft.volume=7&rft.issue=1&rft.spage=11&rft.epage=11&rft.eissn=2047-2994&rft.issn=2047-2994&rft.au=MULLER,%20Allison&BERTRAND,%20Xavier&ROGUES,%20Anne-Marie&PEFAU,%20Muriel&ALFANDARI,%20Serge&rft.genre=article |
